Healthcare provider profile · identity verified

Shirley C Tom, MD

Geriatric Medicine · DEARBORN, MI · NPI 1639483084

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	403	121
Levothyroxine Sodium	Levothyroxine Sodium	275	76
Amlodipine Besylate	Amlodipine Besylate	273	84
Lisinopril	Lisinopril	219	59
Losartan Potassium	Losartan Potassium	181	57
Rosuvastatin Calcium	Rosuvastatin Calcium	169	51
Metformin Hcl	Metformin Hcl	139	47
Metoprolol Succinate	Metoprolol Succinate	138	43
Gabapentin	Gabapentin	128	40
Omeprazole	Omeprazole	124	43
Metoprolol Tartrate	Metoprolol Tartrate	116	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	115	37
Hydrochlorothiazide	Hydrochlorothiazide	100	34
Clopidogrel	Clopidogrel Bisulfate	92	26
Albuterol Sulfate Hfa	Albuterol Sulfate	83	40
Pantoprazole Sodium	Pantoprazole Sodium	82	26
Furosemide	Furosemide	75	34
Famotidine	Famotidine	74	34
Sertraline Hcl	Sertraline Hcl	71	23
Hydralazine Hcl	Hydralazine Hcl	69	19
Fluticasone Propionate	Fluticasone Propionate	62	23
Alprazolam	Alprazolam	61	26
Alendronate Sodium	Alendronate Sodium	59	14
Tamsulosin Hcl	Tamsulosin Hcl	59	18
Montelukast Sodium	Montelukast Sodium	57	16
Metformin Hcl Er	Metformin Hcl	55	18
Eliquis	Apixaban	51	21
Mirtazapine	Mirtazapine	51	19
Duloxetine Hcl	Duloxetine Hcl	47	14
Atenolol	Atenolol	46	suppressed
Tramadol Hcl	Tramadol Hcl	46	15
Spironolactone	Spironolactone	45	19
Allopurinol	Allopurinol	43	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	43	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	41	13
Januvia	Sitagliptin Phosphate	41	11
Cephalexin	Cephalexin	40	31
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	40	suppressed
Diclofenac Sodium	Diclofenac Sodium	39	15
Baclofen	Baclofen	38	suppressed
Ventolin Hfa	Albuterol Sulfate	38	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	14
Olmesartan Medoxomil	Olmesartan Medoxomil	36	14
Trazodone Hcl	Trazodone Hcl	35	suppressed
Prednisone	Prednisone	34	16
Carvedilol	Carvedilol	33	12
Pregabalin	Pregabalin	33	15
Simvastatin	Simvastatin	33	14
Finasteride	Finasteride	32	11
Breo Ellipta	Fluticasone/Vilanterol	31	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	30	11
Amiodarone Hcl	Amiodarone Hcl	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Jardiance	Empagliflozin	26	suppressed
Tizanidine Hcl	Tizanidine Hcl	26	14
Xarelto	Rivaroxaban	26	suppressed
Folic Acid	Folic Acid	25	suppressed
Memantine Hcl Er	Memantine Hcl	25	suppressed
Spiriva Respimat	Tiotropium Bromide	25	suppressed
Glipizide Er	Glipizide	24	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	24	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Naproxen	Naproxen	23	suppressed
Glipizide	Glipizide	22	suppressed
Symbicort	Budesonide/Formoterol Fumarate	22	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	22	suppressed
Donepezil Hcl	Donepezil Hcl	21	13
Methocarbamol	Methocarbamol	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	20	suppressed
Glimepiride	Glimepiride	20	suppressed
Lidocaine	Lidocaine	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Azithromycin	Azithromycin	19	17
Farxiga	Dapagliflozin Propanediol	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Ozempic	Semaglutide	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Potassium Chloride	Potassium Chloride	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Lorazepam	Lorazepam	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	11
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Ibuprofen	Ibuprofen	17	11
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Anastrozole	Anastrozole	16	suppressed
Bumetanide	Bumetanide	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	12
Clotrimazole	Clotrimazole	15	11
Ketoconazole	Ketoconazole	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Briviact	Brivaracetam	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Lactulose	Lactulose	13	suppressed
Meloxicam	Meloxicam	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Risedronate Sodium	Risedronate Sodium	12	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Calcitriol	Calcitriol	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error